| Cl | chloride; chlorine; clavicle; clear; clinic; Clostridium; closure; colistin |
|---|---|
| VCA | vancomycin, colistin, and anisomycin; viral capsid antigen |
| HC | hair cell; hairy cell; handicapped; head circumference; head compression; health care; healthy contr... |
| HCA | heart cell aggregate; hepatocellular adenoma; home care aide; Hospital Corporation of America; hydro... |
| HSHC | hydrocortisone hemisuccinate |
| HS | Hindlimb suspension |
|---|---|
| PSIFT | Platelet Suspension Immunofluorescence Test |
| TST | Tail Suspension Test |
| Cortisol | Hydrocortisone |
| HC | Hydrocortisone |
| thonzonium bromide | Hexadecyl[2-[(p-methoxybenzyl)-2-pyrimidinylamino]ethyl]dimethylammonium bromide;a surface-active agent used in ear drops and aerosols. (05 Mar 2000) |
|---|---|
| colistin | <chemical> Cyclic polypeptide antibiotic from bacillus colistinus. It is composed of polymyxins e1 and e2 (or colistins a, b, and c) which act as detergents on cell membranes. Colistin is less toxic than polymyxin b, but otherwise similar; the methanesulfonate is used orally. Pharmacological action: antibiotics, peptide. Chemical name: Colistin (12 Dec 1998) |
| colistin sulfomethate sodium | Pentasodium colistinmethanesulfonate;contains the pentasodium salt of the penta(methanesulfonic acid) derivative of colistin A as the major component, with a small proportion of the pentasodium salt of the same derivative of colistin B; an effective antibiotic against most Gram-negative bacilli (except Proteus), given intramuscularly. See: colistin sulfate, polymyxin. Synonym: cholistine sulphomethate sodium, colistin sulfomethate sodium. (05 Mar 2000) |
| neomycin | <drug> Either of two aminoglycosides (B & C) produced by Streptomyces fradiae that have generalised antibiotic activity. Neomycin A (Ineamine) contains 2 deoxy 1,3 diamino inositol combined with the aminoglycoside. (18 Nov 1997) |
| neomycin sulfate | The sulfate of an antibacterial antibiotic substance produced by the growth of Streptomyces fradiae, active against a variety of Gram-positive and Gram-negative bacteria. (05 Mar 2000) |
| hydrocortisone | <chemical> (11 beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione. The main glucocorticoid secreted by the adrenal cortex. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Pharmacological action: steroidal anti-inflammatory agents. Chemical name: Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)- (12 Dec 1998) |
| hydrocortisone acetate | Hydrocortisone 21-acetate;similar actions and uses as hydrocortisone. Synonym: cortisol acetate. (05 Mar 2000) |
| hydrocortisone cyclopentylpropionate | An ester of hydrocortisone. (05 Mar 2000) |
| hydrocortisone cypionate | The cyclopentanepropionic ester of cortisone, for oral administration. (05 Mar 2000) |
| hydrocortisone hydrogen succinate | A form of hydrocortisone administered intravenously. (05 Mar 2000) |
| hydrocortisone sodium phosphate | Hydrocortisone 21-(disodium phosphate);an anti-inflammatory agent for intravenous or intramuscular administration. (05 Mar 2000) |
| hydrocortisone sodium succinate | A very soluble ester salt of hydrocortisone (cortisol), used parenterally in the management of emergencies resulting from acute adrenal insufficiency. (05 Mar 2000) |
| hydrocortisone, topical | Hydrocortisone that is applied topically as an anti-inflammatory agent. (12 Dec 1998) |
| amorphous insulin zinc suspension | Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection. Synonym: amorphous insulin zinc suspension, semilente insulin. (05 Mar 2000) |
| magnesia and alumina oral suspension | A mixture of magnesium hydroxide and variable amounts of aluminum oxide; used as an antacid. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|